1. Home
  2. CVKD vs RAYA Comparison

CVKD vs RAYA Comparison

Compare CVKD & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • RAYA
  • Stock Information
  • Founded
  • CVKD 2022
  • RAYA 2019
  • Country
  • CVKD United States
  • RAYA China
  • Employees
  • CVKD N/A
  • RAYA N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • RAYA Metal Fabrications
  • Sector
  • CVKD Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • CVKD Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • CVKD 31.5M
  • RAYA 34.2M
  • IPO Year
  • CVKD 2023
  • RAYA 2022
  • Fundamental
  • Price
  • CVKD $16.80
  • RAYA $1.44
  • Analyst Decision
  • CVKD Strong Buy
  • RAYA
  • Analyst Count
  • CVKD 1
  • RAYA 0
  • Target Price
  • CVKD $32.00
  • RAYA N/A
  • AVG Volume (30 Days)
  • CVKD 20.0K
  • RAYA 18.5K
  • Earning Date
  • CVKD 05-08-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • CVKD N/A
  • RAYA N/A
  • EPS Growth
  • CVKD N/A
  • RAYA N/A
  • EPS
  • CVKD N/A
  • RAYA N/A
  • Revenue
  • CVKD N/A
  • RAYA $30,300,360.00
  • Revenue This Year
  • CVKD N/A
  • RAYA $64.53
  • Revenue Next Year
  • CVKD N/A
  • RAYA $9.61
  • P/E Ratio
  • CVKD N/A
  • RAYA N/A
  • Revenue Growth
  • CVKD N/A
  • RAYA N/A
  • 52 Week Low
  • CVKD $5.70
  • RAYA $0.56
  • 52 Week High
  • CVKD $22.90
  • RAYA $1.90
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 49.81
  • RAYA 52.16
  • Support Level
  • CVKD $15.85
  • RAYA $1.44
  • Resistance Level
  • CVKD $17.33
  • RAYA $1.90
  • Average True Range (ATR)
  • CVKD 1.31
  • RAYA 0.16
  • MACD
  • CVKD 0.21
  • RAYA 0.01
  • Stochastic Oscillator
  • CVKD 82.32
  • RAYA 41.03

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: